1. Home
  2. EWTX vs PRKS Comparison

EWTX vs PRKS Comparison

Compare EWTX & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EWTX
  • PRKS
  • Stock Information
  • Founded
  • EWTX 2017
  • PRKS 1959
  • Country
  • EWTX United States
  • PRKS United States
  • Employees
  • EWTX N/A
  • PRKS N/A
  • Industry
  • EWTX Biotechnology: Pharmaceutical Preparations
  • PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EWTX Health Care
  • PRKS Health Care
  • Exchange
  • EWTX Nasdaq
  • PRKS Nasdaq
  • Market Cap
  • EWTX 1.4B
  • PRKS 2.4B
  • IPO Year
  • EWTX 2021
  • PRKS 2013
  • Fundamental
  • Price
  • EWTX $13.71
  • PRKS $47.52
  • Analyst Decision
  • EWTX Buy
  • PRKS Buy
  • Analyst Count
  • EWTX 9
  • PRKS 13
  • Target Price
  • EWTX $39.89
  • PRKS $57.92
  • AVG Volume (30 Days)
  • EWTX 791.6K
  • PRKS 717.3K
  • Earning Date
  • EWTX 08-07-2025
  • PRKS 08-06-2025
  • Dividend Yield
  • EWTX N/A
  • PRKS N/A
  • EPS Growth
  • EWTX N/A
  • PRKS 3.53
  • EPS
  • EWTX N/A
  • PRKS 3.85
  • Revenue
  • EWTX N/A
  • PRKS $1,714,827,000.00
  • Revenue This Year
  • EWTX N/A
  • PRKS $2.47
  • Revenue Next Year
  • EWTX N/A
  • PRKS $2.32
  • P/E Ratio
  • EWTX N/A
  • PRKS $12.37
  • Revenue Growth
  • EWTX N/A
  • PRKS N/A
  • 52 Week Low
  • EWTX $10.60
  • PRKS $37.68
  • 52 Week High
  • EWTX $38.12
  • PRKS $60.83
  • Technical
  • Relative Strength Index (RSI)
  • EWTX 47.19
  • PRKS 55.39
  • Support Level
  • EWTX $12.51
  • PRKS $48.28
  • Resistance Level
  • EWTX $14.30
  • PRKS $50.35
  • Average True Range (ATR)
  • EWTX 0.67
  • PRKS 1.53
  • MACD
  • EWTX 0.06
  • PRKS 0.27
  • Stochastic Oscillator
  • EWTX 58.15
  • PRKS 62.42

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About PRKS United Parks & Resorts Inc. Common Stock

United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.

Share on Social Networks: